EXAS241220C100000
- 0.05
- 0.000.00%
Exact Sciences Newsroom
Analysts Are Bullish on These Healthcare Stocks: Exact Sciences (EXAS), Neurocrine (NBIX)
Exact Sciences Is Maintained at Buy by B of A Securities
Exact Sciences Analyst Ratings
BofA Securities Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72
TD Cowen Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $86
Exact Sciences (EXAS) Gets a Buy From TD Cowen
A Quick Look at Today's Ratings for Exact Sciences(EXAS.US), With a Forecast Between $67 to $86
What 19 Analyst Ratings Have To Say About Exact Sciences
Exact Sciences Is Maintained at Buy by TD Cowen
Exact Sciences Is Maintained at Buy by BTIG
Exact Sciences Analyst Ratings
BTIG Raises Price Target on Exact Sciences to $75 From $65, Maintains Buy Rating
A Quick Look at Today's Ratings for Exact Sciences(EXAS.US), With a Forecast Between $67 to $86
Piper Sandler Releases a Buy Rating on Exact Sciences (EXAS)
Jefferies Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $85
Exact Sciences (EXAS) Receives a Buy From Jefferies
Exact Sciences Is Maintained at Overweight by Piper Sandler
Exact Sciences Analyst Ratings
Piper Sandler Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $75
Scotiabank Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $70